Plenary Sessions

​​​​​​​​​​​MICROBIOTA, IMMUNITY AND REGULATION

Role of microbiota in atherosclerosis

Fredrik Bäckhed (Sweden)  -  Read more

Immunity in atherosclerosis

Ira Tabas (USA)   -   Rea​d ​more​

Vaccination against atherosclerosis

Johan Kuiper (Netherlands)  -   Read more​

Role of microRNAs in atherosclerosis​

Carlos Fernandez-Hernando (USA)  -   Read more​

 

ENERGY METABOLISM AND DIABETES

Diabetic dyslipidemia

Marja-Riitta Taskinen (Finland)  -   Read more​

Regulation of adipogenesis

Ulf Smith (Sweden)​

NAFLD and NASH​

Philip Newsome (UK)  -   Read more​

Lipotoxic heart disease​

Ira Goldberg (USA) -   Read more​

 

RISK FACTORS AND INTERVENTIONS

Classical and novel risk factors

Naveed Sattar (UK) -   Read more​

Genetic risk factors and Mendelian randomization

Anne Tybjaerg-Hansen (Denmark)​ - Read more

Residual cardiovascular risk: management beyond statins​

Jane Armitage (UK) - Read more

PCSK9 Inhibition

Bertrand Cariou (France)​ - Re​ad more​​​

Keep Me Updated